CBT · XBRL financial data
Cabot financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (CBT's year ends in late September)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 965* | 958 | 1,019 | 1,016 | 1,001* | 955 | 936 | 923 | 899* | 849 | 904 | 982 |
| Cost of goods and services sold | 740* | 740 | 773 | 760 | 761* | 720 | 695 | 679 | 679* | 638 | 694 | 798 |
| Gross profit | 225* | 218 | 246 | 256 | 240* | 235 | 241 | 244 | 220* | 211 | 210 | 184 |
| Research and development | 14* | 15 | 15 | 16 | 17* | 14 | 15 | 15 | 15* | 13 | 14 | 13 |
| Selling, general and administrative | 69* | 67 | 75 | 68 | 73* | 66 | 64 | 62 | 68* | 69 | 67 | 73 |
| Operating income (loss) | 142* | 136 | 156 | 172 | 150* | 155 | 162 | 167 | 137* | 129 | 129 | 98 |
| Interest expense | 21* | 22 | 21 | 19 | 19* | 18 | 19 | 19 | 20* | 18 | 18 | 18 |
| Other income (expense) | (3)* | (29) | (1) | (3) | (3)* | 1 | 1 | 0 | (9)* | — | 2 | (30) |
| Income tax expense (benefit) | (118)* | 34 | 47 | 40 | (10)* | 41 | 49 | 43 | 63* | 37 | 44 | 46 |
| Net income (loss) | 234* | 50 | 84 | 109 | 137* | 93 | 94 | 101 | 43* | 73 | 68 | 6 |
| Earnings per share, basic USD per share | 4.20* | 0.88 | 1.50 | 1.96 | 2.51* | 1.69 | 1.71 | 1.87 | 0.81* | 1.38 | 1.27 | 0.12 |
| Earnings per share, diluted USD per share | 4.18* | 0.88 | 1.49 | 1.94 | 2.47* | 1.67 | 1.69 | 1.86 | 0.80* | 1.37 | 1.27 | 0.12 |
| Weighted average shares, basic millions of shares | 56* | 55 | 55 | 55 | 55* | 54 | 54 | 54 | 53* | 53 | 52 | 52 |
| Weighted average shares, diluted millions of shares | 56* | 56 | 56 | 56 | 56* | 55 | 54 | 54 | 54* | 53 | 52 | 52 |
Balance sheet
CSVFiscal quarters (CBT's year ends in late September)
Cash flows
CSVFiscal quarters (CBT's year ends in late September)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 234* | 50 | 84 | 109 | 137* | 93 | 94 | 101 | 43* | 73 | 68 | 6 |
| Stock-based compensation | 5* | 6 | 7* | 6* | 6* | 8 | 6* | 5* | 5* | 3 | 4* | 6* |
| Depreciation and amortization | 37* | 41 | 37* | 36* | 37* | 37 | 38* | 39* | 40* | 41 | 49* | 50* |
| Net cash from operating activities | 138* | 105 | 176* | 207* | 204* | 124 | 73* | 249* | 219* | 126 | 77* | 75* |
| Purchases of property and equipment | 78* | 54 | 43* | 52* | 92* | 77 | 72* | 61* | 64* | 69 | 45* | 38* |
| Net cash from investing activities | (75)* | (54) | (41)* | (51)* | (89)* | (104) | (70)* | (65)* | (59)* | (69) | (109)* | (38)* |
| Proceeds from issuing common stock | 0* | 7 | 6* | 2* | 5* | 2 | 0* | 0* | 6* | — | — | — |
| Share repurchases | 50* | 33 | 24* | 49* | 66* | 42 | 47* | 40* | 39* | 52 | 49* | 0* |
| Dividends paid | 23* | 22 | 23* | 24* | 24* | 24 | 23* | 24* | 25* | 24 | 24* | 24* |
| Proceeds from long-term debt | 5* | 0 | 0* | 14* | 1* | 6 | 0* | 9* | 0* | — | — | — |
| Repayments of long-term debt | 2* | 1 | 8* | 20* | 1* | 1 | 3* | 1* | 2* | 2 | 2* | 129* |
| Net cash from financing activities | (32)* | (29) | (166)* | (131)* | (89)* | (24) | 17* | (183)* | (146)* | (92) | 53* | (49)* |
| Net change in cash | 18* | 6 | (38)* | (9)* | 26* | (40) | 30* | 26* | 19* | (28) | 22* | (1)* |
Compare with peers
SIC 2890 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 2890 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Cabot | 250 | 982 | 75* | 51.6M | 10-QJun 30, 2026 |
| Element Solutions | 225 | 995 | 159* | 242.6M | 10-QSep 30, 2026 |
| Fuller H B | 97 | 938 | 65* | 53.8M | 10-QAug 29, 2026 |
| Orion | 71 | 473 | 58* | 56.5M | 10-QSep 30, 2026 |
| CSW Industrials | 37 | 361 | 95* | 16.3M | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
